BioSpace News Archive

Drug Development

HistoIndex’s Second Harmonic Generation (SHG) Technology: A Potentially Important Tool Used In Madrigal’s Phase 2 Nonalcoholic Steatohepatitis (NASH) Clinical Trial

HistoIndex’s AI-based SHG technology has the potential to yield important results from NASH clinical trials.

December 23, 2018
·
4 min read
FDA

I-Mab Receives U.S. FDA IND Approval for Proprietary Anti-GM-CSF Monoclonal Antibody TJM2

- The first I-Mab proprietary drug candidate to enter clinical trials in the United States

December 23, 2018
·
2 min read
Policy

Braeburn Announces Tentative FDA Approval of BRIXADI™ (buprenorphine) Extended-Release Injection for the Treatment of Moderate to Severe Opioid Use Disorder

BRIXADI™ is a long-acting buprenorphine injectable with both weekly and monthly doses to align with the way healthcare providers treat patients with OUD

December 23, 2018
·
4 min read
Business

DrLupo surpasses $1 million milestone for St. Jude Children’s Research Hospital® during 24-hour Fortnite livestream

Gaming celebrity Benjamin “DrLupo” Lupo involved the online gaming community during a 24-hour Fortnite livestream Saturday to surpass his goal, raising $1.3 million in 2018 to support the mission of St. Jude Children’s Research Hospital: Finding cures.

December 23, 2018
·
3 min read